Specialist expertise, from the lab bench to the dataset.
Agile Biomedical Consultants brings together laboratory scientists, statisticians, epidemiologists and data scientists from leading UK universities. We work with companies, researchers and funders in the UK and, through our base in Hangzhou, across China.
Founded by researchers who took a therapy from the laboratory to Phase Ib clinical trials, we bring the same rigour to every question, in the lab or in the data.
Agile Biomedical Consultants (ABC) combines academic leadership at Anglia Ruskin University, UCL and the University of Cambridge with years of experience delivering for industry, charities and public funders.
We are agile by design: small senior teams, tailored to each project, communicating openly at every stage and focused on the outcome you need, whether that is a robust dataset, a validated assay or a go/no-go decision.
More about usTwo practices, one team
Each service is led by active researchers in that field. Many projects draw on both practices.
Laboratory and translational science
Assays, drug testing and diagnostics, led by researchers with four decades of cancer biology experience.
DNA Damage and Repair
Detecting and measuring DNA damage and repair, to understand disease and test new treatments.
ExploreDrug Development and Testing
In vitro studies and in vivo guidance to evaluate new therapeutics efficiently and accurately.
ExploreDisease Diagnosis and Detection
Accurate, validated methods for early detection and monitoring of disease.
ExploreData, statistics and population health
Statistics, bioinformatics, epidemiology and study delivery, for biomedical and non-biomedical questions alike.
Statistics, Bioinformatics and Data Science
Rigorous statistics and computational analysis for complex data, in biomedicine and beyond.
ExploreStudy Design and Implementation
Designing and running robust, high-quality cohort and population health studies.
ExploreTraining and Networking
Hands-on research training and networking in population health and ageing research.
ExploreA clear path from question to answer
Consult
A free initial discussion to understand your goals, constraints and timelines.
Design
A tailored proposal, with methods matched to the question.
Deliver
Laboratory, analytical or fieldwork delivered by specialists, with open communication throughout.
Report
Clear reports covering the work, the results and our recommendations.
One team, two bases
Our UK company works alongside our operation in Linping District, Hangzhou, giving partners in both countries access to UK academic expertise and to China's research and manufacturing capacity.
Senior people on every project

Dr Hussein Al-Ali
DirectorSenior Lecturer, Anglia Ruskin University, Cambridge
Prof Chris Parris
DirectorProfessor and Head of the School of Life Sciences, Anglia Ruskin UniversityDr Shabina Hayat
Consultant, population health and cognitive ageingVisiting Researcher, UCL and University of CambridgeDr Sarah Assaad
Consultant, epidemiology and statisticsLecturer in Epidemiology and Statistics, UCLDr Timothy Hearn
Consultant, bioinformatics and data scienceSenior Lecturer in Bioinformatics, Anglia Ruskin University; Affiliated Associate Professor, University of CambridgeBacked by more than 200 publications
Our team publishes in journals including Oncogene, Alzheimer's & Dementia, Current Biology and the BMJ. Browse the full list and preview abstracts from PubMed.
Browse publicationsABC Cambridge maintained fully open and transparent lines of communication, quickly addressing any queries raised. The consultancy report produced by ABC Cambridge provided the required level of ‘comfort’ to the Copperchase directorate, enabling a decision to be made on progression of the proposed project.
Latest from Agile Biomedical
£1m investment for our China platform
Our Cambridge UK Biopharmaceutical R&D Service Platform has been approved as a pioneer talent initiative in Hangzhou, securing more than £1 million in funding.
Read moreAgreement signed with GDLST
A strategic agreement with Beijing-based Global Detian Life Sciences Technology for the joint development and manufacture of oncology therapeutics.
Read moreAt Advanced Therapies 2024
Our team joined one of Europe's largest gatherings on cell and gene therapies, at ExCeL London.
Read moreTell us about your project
Your first consultation is free. We will propose an approach, a timeline and costs tailored to your goals.
